The U.S. biotechnology sector is witnessing a remarkable transformation. MEI Pharma announced a groundbreaking decision on July 22, securing full ownership of LTC with a financing of $100 million, using it as the company's primary reserve asset. This move makes MEI Pharma the first publicly traded company in the U.S. to incorporate LTC into its corporate financial reserves, marking a deep integration between traditional enterprises and the world of Crypto Assets.
This financing was conducted through a private placement, issuing nearly 29.24 million shares of common stock or equivalent warrants
This financing was conducted through a private placement, issuing nearly 29.24 million shares of common stock or equivalent warrants
LTC-2.48%